Waycross Partners LLC Buys 15,000 Shares of Danaher Corporation $DHR

Key Points

• Waycross Partners LLC increased its stake in Danaher by 461.5% in Q4, purchasing 15,000 shares to hold 18,250 shares worth about $4.18 million.
• Danaher beat Q4 estimates with $2.23 EPS (vs. $2.14) and $6.84B revenue, and raised its quarterly dividend from $0.32 to $0.40 (annualized $1.60, ~0.9% yield).
• Analysts have a consensus rating of "Moderate Buy" on Danaher with a consensus price target of $253.55 (19 Buys, 3 Holds).

Waycross Partners LLC increased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 461.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 18,250 shares of the conglomerate's stock after purchasing an additional 15,000 shares during the quarter. Waycross Partners LLC's holdings in Danaher were worth $4,178,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Sivia Capital Partners LLC lifted its holdings in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock worth $397,000 after acquiring an additional 119 shares during the last quarter. CreativeOne Wealth LLC raised its position in Danaher by 38.6% in the 2nd quarter. CreativeOne Wealth LLC now owns 2,432 shares of the conglomerate's stock worth $480,000 after purchasing an additional 677 shares during the period. Advisors Asset Management Inc. lifted its stake in Danaher by 11.2% in the second quarter. Advisors Asset Management Inc. now owns 7,218 shares of the conglomerate's stock worth $1,426,000 after purchasing an additional 725 shares during the last quarter. J.W. Cole Advisors Inc. lifted its stake in Danaher by 54.9% in the second quarter. J.W. Cole Advisors Inc. now owns 4,429 shares of the conglomerate's stock worth $875,000 after purchasing an additional 1,569 shares during the last quarter. Finally, Choreo LLC boosted its position in shares of Danaher by 23.1% during the second quarter. Choreo LLC now owns 18,636 shares of the conglomerate's stock valued at $3,687,000 after buying an additional 3,493 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Robert W. Baird set a $251.00 price target on Danaher in a report on Thursday, January 29th. Evercore restated an "outperform" rating and set a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Leerink Partners upped their price objective on Danaher from $260.00 to $270.00 and gave the company an "outperform" rating in a research report on Friday, January 16th. KeyCorp reiterated an "overweight" rating on shares of Danaher in a research note on Thursday, January 29th. Finally, Wells Fargo & Company lifted their target price on Danaher from $230.00 to $240.00 and gave the stock an "equal weight" rating in a research report on Monday, December 15th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $253.55.

Insider Activity at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company's stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company's stock.

Danaher Trading Down 3.4%

Shares of NYSE DHR opened at $181.65 on Friday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The firm has a market cap of $128.55 billion, a PE ratio of 36.04, a price-to-earnings-growth ratio of 2.55 and a beta of 0.93. The business has a fifty day simple moving average of $209.30 and a two-hundred day simple moving average of $214.40. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business's revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.14 earnings per share. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This is a positive change from Danaher's previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher's payout ratio is 25.40%.

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.